StockNews.com Initiates Coverage on Syros Pharmaceuticals (NASDAQ:SYRS)
Stock analysts at StockNews.com began coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research note issued on Tuesday. The brokerage set a “sell” rating on the stock. Several other analysts have also recently issued reports on SYRS. JMP Securities reaffirmed a “market perform” rating on shares of Syros Pharmaceuticals in […]
Stock analysts at StockNews.com began coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research note issued on Tuesday. The brokerage set a “sell” rating on the stock. Several other analysts have also recently issued reports on SYRS. JMP Securities reaffirmed a “market perform” rating on shares of Syros Pharmaceuticals in […]
